Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06067386
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2023-09-22
Brief Title:
Selective Reporting for Antibiotic Susceptibility Testing and GPs Prescribing of Broad-spectrum Antibiotics in Women With E Coli UTIs
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
Selective Reporting for Antibiotic Susceptibility Testing and GPs Prescribing of Broad-spectrum Antibiotics in Women With E Coli UTIs
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ABC-MG
Brief Summary:
The control of antibiotic resistance requires a reduction in inappropriate prescriptions of broad-spectrum antibiotics amoxillin-clavulanate AMC fluoroquinolones FQ third-generation cephalosporins C3G particularly for urinary tract infections treated in primary care Several studies have reported the positive impact of antibiotic susceptibility testing performed on urine cultures on the appropriate use of antibiotics
The selective reporting for antibiotic susceptibility testing defined as the restriction of the list of antibiotics mentioned in the report according to the antibiotic resistance profile would allow according to observational studies a reduction of 25 to 70 of the initial prescriptions of broad-spectrum antibiotics and a 20 rate of antibiotic de-escalation reduction of the antibacterial spectrum of an antibiotic treatment after re-evaluation
The objective is to assess the impact of disseminating a selective reporting for antibiotic susceptibility testing on the dispensing of broad-spectrum antibiotics prescribed by general practitioners GPs for E coli positive urine cultures in adult women compared to the dissemination of a standard antibiotic susceptibility testing
The selective reporting for antibiotic susceptibility testing defined as the restriction of the list of antibiotics mentioned in the report according to the antibiotic resistance profile would allow according to observational studies a reduction of 25 to 70 of the initial prescriptions of broad-spectrum antibiotics and a 20 rate of antibiotic de-escalation reduction of the antibacterial spectrum of an antibiotic treatment after re-evaluation
The objective is to assess the impact of disseminating a selective reporting for antibiotic susceptibility testing on the dispensing of broad-spectrum antibiotics prescribed by general practitioners GPs for E coli positive urine cultures in adult women compared to the dissemination of a standard antibiotic susceptibility testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None